| 169651 | 169651 | Preop Chemoradiation Resectable Pancreas | Completed | No Results Available | Pancreatic Neoplasms | Drug: Avastin (Bevacizumab)|Drug: Gemcitabine|Procedure: Radiation Therapy | https://ClinicalTrials.gov/show/NCT00336648 |
| 169652 | 169652 | Safety and Immunogenicity of CJ-50300 | Completed | No Results Available | Smallpox | Biological: cell-culture derived smallpox vaccine | https://ClinicalTrials.gov/show/NCT00336635 |
| 169653 | 169653 | Efficacy of Wrist/Hand Splints and Tendon/Nerve Gliding Exercises for Carpal Tunnel Syndrome: A RCT | Completed | No Results Available | Carpal Tunnel Syndrome | Device: Splint fabricated by an OT versus an off-the-shelf splint | https://ClinicalTrials.gov/show/NCT00336622 |
| 169654 | 169654 | TRIAD Burden of Illness Mucositis Study | Recruiting | No Results Available | Gastrointestinal Mucositis (Defined as Mucositis Involving the Mouth, Esophagus, or Small Intestine) | | https://ClinicalTrials.gov/show/NCT00336609 |
| 169655 | 169655 | Ultrasound Enhanced Thrombolytic Therapy of Middle Cerebral Artery Occlusion | Recruiting | No Results Available | Intracranial Embolism|Thrombosis | Procedure: transcranial ultrasound in patients treated with iv t-PA | https://ClinicalTrials.gov/show/NCT00336596 |
| 169656 | 169656 | Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin as 2nd Line Therapy for Non-Hodgkin's Lymphoma (NHL) | Completed | Has Results | Non-Hodgkin's Lymphoma | Drug: Oxaliplatin | https://ClinicalTrials.gov/show/NCT00336583 |
| 169657 | 169657 | Predictive Medicine Research. (PRE MED) | Completed | No Results Available | Cardiovascular Diseases | | https://ClinicalTrials.gov/show/NCT00336570 |
| 169658 | 169658 | Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy | Completed | No Results Available | Multiple Sclerosis | Procedure: NAbs testing | https://ClinicalTrials.gov/show/NCT00336557 |
| 169659 | 169659 | Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia | Completed | Has Results | Pneumonia | Drug: Cethromycin|Drug: Clarithromycin | https://ClinicalTrials.gov/show/NCT00336544 |
| 169660 | 169660 | Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation | Completed | No Results Available | Neuroblastoma|Brain Tumor|Retinoblastoma|Wilms Tumor|Mycoses | Drug: itraconazole | https://ClinicalTrials.gov/show/NCT00336531 |
| 169661 | 169661 | Continuing Treatment With Pegasys and Copegus | Recruiting | No Results Available | Chronic Hepatitis C | Drug: peginterferon alfa-2a|Drug: ribavirin | https://ClinicalTrials.gov/show/NCT00336518 |
| 169662 | 169662 | Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia (CAP) | Completed | Has Results | Pneumonia | Drug: Cethromycin|Drug: Clarithromycin | https://ClinicalTrials.gov/show/NCT00336505 |
| 169663 | 169663 | A Study of the Safety and Efficacy of Infliximab(REMICADE ) in Pediatric Patients With Moderately to SeverelyActive Ulcerative Colitis | Completed | Has Results | Ulcerative Colitis | Biological: infliximab|Biological: infliximab|Biological: infliximab|Biological: infliximab | https://ClinicalTrials.gov/show/NCT00336492 |
| 169664 | 169664 | Phase 2 Study of VX-950, Pegasys®, and Copegus® in Hepatitis C | Completed | Has Results | Chronic Hepatitis C | Drug: Telaprevir|Drug: Ribavirin|Drug: Pegylated Interferon Alfa 2a|Other: Placebo | https://ClinicalTrials.gov/show/NCT00336479 |
| 169665 | 169665 | The Erythropoietin NeuroProtective Effect: Assessment in CABG Surgery (TENPEAKS) | Completed | No Results Available | Cardiac Surgery|Brain Injury | Drug: Human recombinant erythropoietin | https://ClinicalTrials.gov/show/NCT00336466 |
| 169666 | 169666 | Immunogenicity and Safety of FluBlok Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Pediatrics | Completed | No Results Available | Influenza | Biological: Influenza Vaccination|Biological: Influenza Vaccination | https://ClinicalTrials.gov/show/NCT00336453 |
| 169667 | 169667 | MRSA Colonization in Peripartum Women and Their Offspring | Completed | No Results Available | Pregnancy|Bacterial Colonization | | https://ClinicalTrials.gov/show/NCT00336427 |
| 169668 | 169668 | Five-Year Actively Controlled Clinical Trial in New Onset Juvenile Systemic Lupus Erythematosus Nephritis | Withdrawn | No Results Available | Systemic Lupus Erythematosus Nephritis | Drug: cyclophosphamide-prednisone-azathioprine | https://ClinicalTrials.gov/show/NCT00336414 |
| 169669 | 169669 | Peri-Operative And Long-Term Cardioprotective Properties Of Sevoflurane In High Risk Patients Undergoing Non-Cardiac Surgery | Completed | No Results Available | Non Cardiac Surgery | Drug: Sevoflurane or Propofol | https://ClinicalTrials.gov/show/NCT00336401 |
| 169670 | 169670 | Use of Rapid Diagnostic Tests for Malaria Case Management in Kenya | Completed | No Results Available | Malaria | Device: Paracheck Device | https://ClinicalTrials.gov/show/NCT00336388 |
| 169671 | 169671 | Treatment of Uncomplicated Childhood Malaria in Tanzania by Artemether+Lumefantrine - Efficacy and Genotyping | Completed | No Results Available | Malaria | Drug: artemether-lumefantrine | https://ClinicalTrials.gov/show/NCT00336375 |
| 169672 | 169672 | Evaluating the Safety of G-CSF Mobilization in Individuals With Beta Thalassemia Major | Completed | No Results Available | Beta-Thalassemia | Drug: Hydroxyurea | https://ClinicalTrials.gov/show/NCT00336362 |
| 169673 | 169673 | A Study of Intra-dermal Injection of Botulinum Toxin Type A for the Diabetic Neuropathic Foot Pain | Completed | No Results Available | Diabetes Mellitus|Neuropathic Pain | Drug: Botulinum Toxin Type A | https://ClinicalTrials.gov/show/NCT00336349 |
| 169674 | 169674 | GISSI-HF- Effects of n-3 PUFA and Rosuvastatin on Mortality-Morbidity of Patients With Symptomatic CHF | Completed | No Results Available | Heart Failure | Drug: n-3 PUFA|Drug: Rosuvastatin|Drug: Placebo|Drug: Placebo | https://ClinicalTrials.gov/show/NCT00336336 |
| 169675 | 169675 | A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin) | Completed | Has Results | Diabetic Retinopathy | Procedure: Laser Photocoagulation|Drug: Bevacizumab|Drug: Bevacizumab|Drug: Bevacizumab|Drug: Bevacizumab | https://ClinicalTrials.gov/show/NCT00336323 |
| 169676 | 169676 | A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus Patients | Not yet recruiting | No Results Available | Diabetes Mellitus, Type 2 | Drug: Repaglinide | https://ClinicalTrials.gov/show/NCT00336310 |
| 169677 | 169677 | Testing Methods of Screening for Woman Abuse in Health Care Settings. | Completed | No Results Available | Domestic Violence | Procedure: Woman Abuse Screening Tool|Procedure: Partner Violence Screen|Procedure: Computerized screening|Procedure: Face to face screening|Procedure: Written screening on forms | https://ClinicalTrials.gov/show/NCT00336297 |
| 169678 | 169678 | TRUST: Lumos-T Safely RedUceS RouTine Office Device Follow-up | Completed | Has Results | Patient Indicated for an ICD | Other: Home Monitoring|Other: In-Office Conventional Follow-up | https://ClinicalTrials.gov/show/NCT00336284 |
| 169679 | 169679 | The Effects of Coffee | Completed | No Results Available | Healthy Subjects | | https://ClinicalTrials.gov/show/NCT00336271 |
| 169680 | 169680 | US-Doppler and Procoagulant Microparticles for the Diagnosis of Asymptomatic DVT in Advanced Cancer Patients With Poor Performance Status | Completed | No Results Available | Deep Vein Thrombosis|Cancer | | https://ClinicalTrials.gov/show/NCT00336258 |